# FDA Inspection 1273580 - Otsuka Pharmaceutical Development & Commercialization, Inc - July 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/762d8a44-5e9e-43a3-ae9c-84774676ec0a
Source feed: FDA_Inspections

> FDA Inspection 1273580 for Otsuka Pharmaceutical Development & Commercialization, Inc on July 18, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1273580
- Company Name: Otsuka Pharmaceutical Development & Commercialization, Inc
- Inspection Date: 2025-07-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1273580 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/7e188bd7-5b20-4f3a-a030-2c12ba9f5268)
- [FDA Inspection 1219094 - 2023-09-07](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/1b412766-329c-464a-9391-c8d96d395d36)
- [FDA Inspection 1199647 - 2023-02-27](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/c0b73b40-3560-428f-bc64-42f12e4f294e)
- [FDA Inspection 1074034 - 2018-11-14](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/62885d55-25d4-40e7-ac5c-65cf30ca42d1)
- [FDA Inspection 1012315 - 2017-05-19](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/1e46099a-b4ca-4c96-bfe5-74682079173f)

Company: https://www.keypedia.com/companies/otsuka-pharmaceutical-development-commercialization-inc/03896536-2cca-444e-b073-5c54859f3e6f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c